Skip to content

Effect of a new sedative drug- dexmedetomidine on clear headed recovery after surgery in old patients

Evaluation of dexmedetomidine infusion on post operative delirium in elderly patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/07/014906
Enrollment
74
Registered
2018-07-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- ASA GRADE 1 AND 2 PATIENTS

Interventions

Control Intervention1: NIL: NIL

Sponsors

Rajiv Gandhi Cancer Instiute and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 ASA Class 1 and 2 2 Posted for elective surgery under general anaesthesia. 3 MORE THAN 65 YEARS OF AGE 4 SURGERY OF MORE THAN 2 HOURS DURATION

Exclusion criteria

Exclusion criteria: 1 PATIENTS WITH SICK SINUS SYNDROME 2 2nd AND 3rd DEGREE ATRIOVENTRICULAR BLOCK 3 DISEASE OF THE CENTRAL NERVOUS SYSTEM 4 HISTORY OF HEAD INJURY AND NEUROSURGERY 5 PREEXISTING DEMENTIA OR NEUROLOGICAL DISORDER 6 HISTORY OF CHRONIC ALCOHOL INTAKE AND ANY DRUG ABUSE 7 HISTORY OF TREATMENT FOR ANY PSYCHIATRIC ILLNESS 8 SEVERE HEPATIC OR RENAL DYSFUNCTION 9 PATIENT HAVING COGNITIVE IMPAIRMENT PREOPERATIVELY 10 REFUSAL TO PARTICIPATE IN THE STUDY 11 ALLERGY TO STUDY DRUG

Design outcomes

Primary

MeasureTime frame
POST OPERATIVE DELIRIUM IN ELDERLY PATIENTS UNDERGOING ELECTIVE SURGERY UNDER GENERAL ANESTHESIA WITH PLACEBOTimepoint: 24 HOURS POSTOPERATIVELY FOLLOWED BY EVERY 12 HOURLY TILL 72 HOURS POSTOPERATIVELY

Secondary

MeasureTime frame
TO MEASURE THE REQUIREMENT OF INHALATIONAL ANESTHETIC AGENT IN THE INTRAOPERATIVE PEROID WITH AND WITHOUT THE USE OF DEXMEDETOMIDINE TO MEASURE THE REQUIREMENT OF OPIOIDS/ANALGESICS IN THE PERIOPERATIVE PERIOD WITH AND WITHOUT THE USE OF DEXMEDETOMIDINETimepoint: NIL

Countries

India

Contacts

Public ContactFurkan Ahmed Sayyed

Rajiv Gandhi Cancer Institute and Research Centre

manojb8@gmail.com9968604220

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026